Left Ventricular Hypertrophy
📧 Sign up to get email alerts when something new happens for Left Ventricular Hypertrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
A completed noninterventional, single-center feasibility study evaluating measures of heart failure risk.
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Mechanism of Decompensation Evaluation - Aortic Stenosis
A completed University of Edinburgh clinical trial evaluating the mechanism of decompensation in aortic stenosis, with investigation into my…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. [Phase 4]
A Phase 4 trial comparing sacubitril/valsartan with amlodipine in patients with hypertension and left ventricular hypertrophy.
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Empagliflozin and Cardiac Remodelling in People Without Diabetes [Phase 4]
Phase 4 trial assessing empagliflozin for cardiac remodeling in people without diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease [Phase 4]
Phase 4 clinical trial evaluating the effect of blood pressure control on improvement of left ventricular hypertrophy in hypertension patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-07-14FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Losartan Potassium by Camber Pharmaceuticals, enabling the marketing of a generic Losartan P…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) [Phase 3]
Phase 3 LIFE study update on losartan intervention for hypertension and left ventricular hypertrophy; completed trial.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention [Phase 2, Phase 3]
Phase 2/3 trial investigating the effect of dapagliflozin on myocardial and renal function after aortic valve intervention.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis [Phase 3]
Phase 3 clinical trial update evaluating ACE inhibitors in patients on hemodialysis for left ventricular hypertrophy and hypertension has co…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants [Phase 4]
Phase 4 trial evaluating the combination of Everolimus and Tacrolimus for regression of left ventricular hypertrophy in renal transplant pat…
-
FDA label_change · 2020-08-20FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) filed by Organon LLC, resulting in changes t…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients [Phase 4]
Phase 4 trial updating the effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients with secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? [Phase 4]
Phase 4 trial evaluating whether allopurinol reduces left ventricular hypertrophy in patients with treated hypertension.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? [Phase 4]
Phase 4 trial evaluating whether dapagliflozin can regress left ventricular hypertrophy in patients with type 2 diabetes.
-
FDA approval · 2019-07-05FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for Losartan Potassium Tablets, 25 mg, under ANDA201170.
-
FDA approval · 2019-05-07FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
Supplemental application for Losartan Potassium from Micro Labs Limited has been approved by the FDA.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease [Phase 4]
Phase 4 trial evaluating MetfoRmin and its effects on left ventricular hypertrophy in normotensive patients with coronary artery disease; st…
-
CLINICAL_TRIALS trial_result · 2018-12-03Clinical Trial Update: Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy [Phase 4]
Phase 4 trial investigating the effects of levosimendan in patients eligible for aortic valve replacement with left ventricular hypertrophy;…
-
CLINICAL_TRIALS other · 2018-06-27Clinical Trial Update: Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient [NA]
This clinical trial update notes anemia correction and Fibroblast Growth Factor 23 level assessment in chronic kidney disease and renal tran…
-
CLINICAL_TRIALS research · 2018-05-31Clinical Trial Update: Relationship of Different Electrocardiographic Parameters and Ambulatory Blood Pressure Parameters to Detect Left Ventricular Hypertrophy
Clinical trial update examining how different electrocardiographic and ambulatory blood pressure parameters relate to detecting left ventric…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH [Phase 4]
Phase 4 trial update assessing the efficacy and safety of Valsartan alone and in combination with Nebivolol for hypertensive patients with l…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) [NA]
A completed clinical trial (TEAM Amylose) investigated the frequency of cardiac amyloidosis in Caribbean patients with left ventricular hype…
-
CLINICAL_TRIALS research · 2017-07-17Clinical Trial Update: Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG
A clinical trial update indicates the fimasartan study for hypertensive cardiac disease with left ventricular hypertrophy (ECG-estimated) ha…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy [Phase 4]
Phase 4 clinical trial reporting reduction of left ventricular hypertrophy with eplerenone therapy in patients with hypertension and obstruc…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study
This clinical trial update reports long-term follow-up results for in-centre nocturnal hemodialysis (INHD) in patients with end-stage renal …